Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Investments

Set Alert for Investments

Latest From Investments

ViroVet gets government grant for vaccine work in poultry, ruminants

Belgian start-up ViroVet has received a grant from Flanders Innovation & Entrepreneurship (VLAIO) to spur development of its vaccine technology.

Vaccines R&D

Animalcare sees stock recovery following wholesale divestment

UK firm Animalcare has seen its shares slowly begin to recover since the divestment of its wholesale division.

Investments Operations

New outsourced R&D specialists provide animal health with convenient innovation avenue

With the animal health ecosystem broadening, it is no wonder the industry's leading companies are looking for a helping hand with innovation. Animal Pharm editor Joseph Harvey looks at a new culture of sharing.

R&D Deals

GALVmed receives aid to develop vaccine projects for Africa

GALVmed will receive $10 million in UK government aid to advance vaccine projects in Africa.

Investments R&D

Elanco targets $1.45bn IPO that could be a litmus test for animal health

Elanco has set the terms of its upcoming initial public offering (IPO), which could raise up to $1.45 billion.

Elanco Investments

Hong Kong forum to highlight the latest innovation among Asian start-ups

The latest Animal Health Innovation Asia forum will highlight some of the leading Chinese innovators and several start-ups from the wider Asia Pacific area.

Hong Kong Investments
See All
Advertisement
UsernamePublicRestriction

Register